Authors include Precision Health faculty Bhramar Mukherjee, Brahmajee K. Nallamothu, Sachin Kheterpal, and Lynda Lisabeth, as well as Precision Health Investigators Karandeep Singh and Lars G. Fritsche.

“What we are starting to think about… is to build on our understanding of some of the brain signatures that you see through functional MRIs and incorporate a broader group of biomarkers to better identify patients at risk for the development of chronic pain and markers of resilience,” said Chad Brummett, a member of the research team and Co-I of Precision Health’s Precision Opioid Prescribing use case.

Thomas Gardner, MD, MS, an ophthalmologist at the Kellogg Eye Center, and Jeffrey Sundstrom, MD, PhD, an ophthalmologist at Penn State, are working with colleagues from U-M’s College of Engineering, Michigan Medicine, and the Bioinformatics Core to make an innovative device to extract adequate fluid samples from the eye, helping with diagnosis and individualized treatment plans for patients.

Researchers at the U-M Rogel Cancer Center have developed a new diagnostic approach using artificial intelligence that predicts which stage 0 breast cancers are likely to recur and spread after surgery, and which ones surgery is likely to cure, with greater than 90% accuracy.

Precision Health member Cathy Goldstein, MD, a clinical associate professor of neurology who specializes in sleep disorders, was quoted extensively in a New York Times article about the utility of Apple Watch blood-oxygen data for research and for individuals.